Cargando…

A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder

The treatment of alcohol use disorder (AUD) with sodium oxybate (SMO) or gamma-hydroxybutyric acid (GHB) was introduced in Italy and Austria more than 20 years and 15 years ago, respectively, and it is now widely employed to treat alcohol withdrawal syndrome (AWS) and to maintain alcohol abstinence....

Descripción completa

Detalles Bibliográficos
Autores principales:	Caputo, Fabio, Vignoli, Teo, Tarli, Claudia, Domenicali, Marco, Zoli, Giorgio, Bernardi, Mauro, Addolorato, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808953/ https://www.ncbi.nlm.nih.gov/pubmed/26959045 http://dx.doi.org/10.3390/ijerph13030290

Ejemplares similares

Gamma Hydroxybutyric Acid (GHB) for the Treatment of Alcohol Dependence: A Review
por: Caputo, Fabio, et al.
Publicado: (2009)

Sodium Oxybate: a Substitute for Alcohol?
por: Gual, A., et al.
Publicado: (2022)

Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment Duration
por: Guiraud, Julien, et al.
Publicado: (2023)

Sleep, Narcolepsy, and Sodium Oxybate
por: Mamelak, Mortimer
Publicado: (2022)

Symptoms of Protracted Alcohol Withdrawal in Patients with Alcohol Use Disorder: A Comprehensive Systematic Review
por: Gallus, Silvano, et al.
Publicado: (2023)

Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial
por: Guiraud, Julien, et al.
Publicado: (2022)

Wernicke’s Encephalopathy in Alcohol Use Disorder Patients after Liver Transplantation: A Case Series and Review of Literature
por: Vassallo, Gabriele A., et al.
Publicado: (2020)

Psychosis in Patients with Narcolepsy as an Adverse Effect of Sodium Oxybate
por: Sarkanen, Tomi, et al.
Publicado: (2014)

Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA)
por: Testino, Gianni, et al.
Publicado: (2021)

Sodium oxybate—a new horizon for symptomatic treatment of RBD?
por: Stefani, Ambra, et al.
Publicado: (2023)

Increasing Evidence for the Use of Sodium Oxybate in Multi-Drug-Resistant Lance–Adams Syndrome
por: Riboldi, Giulietta M., et al.
Publicado: (2019)

Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice
por: Drakatos, Panagis, et al.
Publicado: (2017)

Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav(®)) in Sleep Disorders: A Profile of Its Use
por: Heo, Young-A
Publicado: (2022)

REM Sleep Behavior Disorder in Children With Type 1 Narcolepsy Treated With Sodium Oxybate
por: Antelmi, Elena, et al.
Publicado: (2021)

Off-label Sodium Oxybate in Childhood Narcolepsy: A Comprehensive Report
por: Miskoff, Jeffrey A, et al.
Publicado: (2018)

Evaluation of the Effectiveness of the Risk Minimization Measures of Sodium Oxybate in the European Union
por: Iranzo, Alex, et al.
Publicado: (2020)

Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate
por: Schneider, Logan D, et al.
Publicado: (2023)

Correction to: Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav(®)) in Sleep Disorders: A Profile of Its Use
por: Heo, Young-A
Publicado: (2022)

Long-term Effect of Sodium Oxybate (Xyrem®) in Spasmodic Dysphonia with Vocal Tremor
por: Simonyan, Kristina, et al.
Publicado: (2013)

A Case of Off-label Sodium Oxybate in an 11-Year-Old with Narcolepsy
por: Miskoff, Jeffrey A, et al.
Publicado: (2019)

Sodium oxybate in treatment-resistant rapid-eye-movement sleep behavior disorder
por: During, Emmanuel H, et al.
Publicado: (2023)

Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
por: Bogan, Richard K, et al.
Publicado: (2020)

Corrigendum to: Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
por: Bogan, Richard K, et al.
Publicado: (2021)

Corrigendum to: Efficacy and Safety of Calcium, Magnesium, Potassium, and Sodium Oxybates (Lower-Sodium Oxybate [LXB]; JZP-258) in a Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adults With Narcolepsy With Cataplexy
por: Bogan, Richard K, et al.
Publicado: (2021)

Sodium Oxybate: A Cause of Extreme Involuntary Weight Loss in a Young Lady
por: Noujaim, Michael G., et al.
Publicado: (2019)

Decreased body mass index during treatment with sodium oxybate in narcolepsy type 1
por: Schinkelshoek, Mink S., et al.
Publicado: (2018)

Preferences for Attributes of Sodium Oxybate Treatment: A Discrete Choice Experiment in Patients with Narcolepsy
por: Dubow, Jordan, et al.
Publicado: (2022)

Correction to: Sodium oxybate in treatment-resistant rapid-eye-movement sleep behavior disorder
Publicado: (2023)

O024 Sodium oxybate for refractory narcolepsy and idiopathic hypersomnia: clinical and employment outcomes
por: Hernest, A, et al.
Publicado: (2023)

Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence
por: Mosoni, Carolina, et al.
Publicado: (2018)

Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing
por: Feldman, Neil T.
Publicado: (2009)

Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial
por: Spaeth, Michael, et al.
Publicado: (2012)

A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome
por: George, Charles F. P., et al.
Publicado: (2010)

Resolution of Sleepwalking Behavior after Initiation of Sodium Oxybate in a Patient with Narcolepsy Type 2
por: Hesselbacher, Sean, et al.
Publicado: (2018)

Long-term follow-up on the effects of sodium oxybate on daytime sleepiness and sleep architecture in patients with narcolepsy type 1
por: Peraita-Adrados, Rosa, et al.
Publicado: (2023)

Alcohol use disorder in the COVID‐19 era: Position paper of the Italian Society on Alcohol (SIA)
por: Testino, Gianni, et al.
Publicado: (2021)

Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight‐Based Dosing in Children and Adolescents With Narcolepsy With Cataplexy
por: Chen, Cuiping, et al.
Publicado: (2020)

Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study
por: Addolorato, Giovanni, et al.
Publicado: (2018)

Author Correction: Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study
por: Addolorato, Giovanni, et al.
Publicado: (2018)

Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
por: Dauvilliers, Yves, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uketb4ng7vr849vfei0trbdofq